ANTHRASIL DIN 02469588
Status: Restricted Access
Holder: EMERGENT BIOSOLUTIONS CANADA INC.
Molecule: ANTHRAX IMMUNOGLOBULIN (HUMAN)
Health Canada record
| Active ingredient(s) | ANTHRAX IMMUNOGLOBULIN (HUMAN) 60 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J06BB19 ANTHRAX IMMUNOGLOBULIN |
| Original market date | |
| Current status date | 26-Sep-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Emergent BioSolutions Canada Inc. — licence 3-002450, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20008 | 2017-11-06 | New Drug Submission (NDS) |